NATERA, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
NATERA, INC. (NTRA) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount of $961.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther · last filed 2026-02-27
- NATERA, INC. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2025 was $961.00K, a 66.52% decline from fiscal 2024.
- NATERA, INC. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2024 was $2.87M.
- NATERA, INC. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2023 was -$3.40M, a 272.96% decline from fiscal 2022.
- NATERA, INC. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2022 was $1.96M, a 470.93% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $961.00K 10-K · filed 2026-02-27 | |
| 2024-12-31 | $2.87M 10-K · filed 2025-02-28 | |
| 2023-12-31 | -$3.40M 10-K · filed 2025-02-28 | |
| 2022-12-31 | $1.96M 10-K · filed 2025-02-28 | |
| 2021-12-31 | $344.00K 10-K · filed 2024-02-29 | |
| 2020-12-31 | $792.00K 10-K · filed 2023-03-01 | $9.78M 10-K · filed 2021-02-26 |
| 2019-12-31 | $769.00K 10-K · filed 2022-02-25 | $1.38M 10-K · filed 2020-03-02 |
| 2018-12-31 | $690.00K 10-K · filed 2021-02-26 | $885.00K 10-K · filed 2019-03-15 |
| 2017-12-31 | $856.00K 10-K · filed 2020-03-02 | $1.01M 10-K · filed 2018-03-15 |
| 2016-12-31 | $933.00K 10-K · filed 2019-03-15 | |
| 2015-12-31 | $841.00K 10-K · filed 2018-03-15 | |
| 2014-12-31 | $414.00K 10-K · filed 2016-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |